United States · FDA National Drug Code directory
Ery-Ped
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24338-130_0ca6c02b-5b9f-39c3-e063-6294a90a4c18
- Product NDC
- 24338-130
- Form
- SUSPENSION
- Composition / generic term
- Erythromycin Ethylsuccinate
- Labeler
- Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
- Marketing category
- NDA
- Marketing start / end (source format)
- 20120614
- Source listing expiry
- 20261231
Source-listed ingredients
- ERYTHROMYCIN ETHYLSUCCINATE — 400 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 100 mL in 1 BOTTLE (24338-130-13) · 24338-130-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →